UK Allergy Diagnostics And Therapeutics Market Size & Outlook
UK allergy diagnostics and therapeutics market, 2018-2030 (US$M)
Related Markets
UK allergy diagnostics and therapeutics market highlights
- The UK allergy diagnostics and therapeutics market generated a revenue of USD 893.0 million in 2023 and is expected to reach USD 1,394.7 million by 2030.
- The UK market is expected to grow at a CAGR of 6.6% from 2024 to 2030.
- In terms of segment, inhaled was the largest revenue generating allergen type in 2023.
- Other Allergens is the most lucrative allergen type segment registering the fastest growth during the forecast period.
Allergy diagnostics and therapeutics market data book summary
| Market revenue in 2023 | USD 893.0 million |
| Market revenue in 2030 | USD 1,394.7 million |
| Growth rate | 6.6% (CAGR from 2023 to 2030) |
| Largest segment | Inhaled |
| Fastest growing segment | Other Allergens |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhaled, Drug, Other Allergens, Food |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, UK accounted for 2.8% of the global allergy diagnostics and therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany allergy diagnostics and therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,394.7 million by 2030.
Inhaled was the largest segment with a revenue share of 49.48% in 2023. Horizon Databook has segmented the UK allergy diagnostics and therapeutics market based on inhaled, drug, other allergens, food covering the revenue growth of each sub-segment from 2018 to 2030.
The rise in research activities related to allergies and the growing prevalence of allergies contribute to the region's allergy diagnostics and therapeutics market. The availability of advanced test procedures further helps in boosting the market growth.
For instance, in June 2022, Oncologica, a UK-based company, launched a new Allergyfocus test, which will help patients manage different types of allergies and determine the common types of global allergens their bodies react to. Furthermore, the availability of dedicated organizations such as Allergy UK, which helps adults and children with allergies, is boosting the market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK allergy diagnostics and therapeutics market size, by allergen type, 2018-2030 (US$M)
UK Allergy Diagnostics And Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
